Patents by Inventor Michael J. Lamson

Michael J. Lamson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations and Methods for Attenuating Respiratory Depression Induced by Opioid Overdose
    Publication number: 20170367987
    Abstract: The invention relates to compositions and methods for attenuating opioid induced respiratory depression. Such compositions comprise opioids and sequestered opioid antagonists in a multi-particulate dosage formulation.
    Type: Application
    Filed: April 27, 2017
    Publication date: December 28, 2017
    Inventors: Michael J. Lamson, Veeraindar Goli
  • Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
    Patent number: 9682033
    Abstract: Methods of treating postherpetic neuralgia in a mammal with a pharmaceutical composition comprising a spiro-oxindole compound of the formula: are disclosed. The methods provide excellent penetration of the spiro-oxindole compound into the affected skin area to effectively reduce the severity of the postherpetic neuralgia and/or to alleviate the postherpetic neuralgia with minimal or negligible systemic exposure of the spiro-oxindole compound.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: June 20, 2017
    Assignee: Teva Pharmaceuticals International GmbH
    Inventors: Michael Fetell, Richard Malamut, Michael J. Lamson, Ofer Spiegelstein, Yigal Paul Goldberg, Nicola Anne Price
  • METHODS OF TREATING POSTHERPETIC NEURALGIA WITH A TOPICAL FORMULATION OF A SPIRO-OXINDOLE COMPOUND
    Publication number: 20160228354
    Abstract: Methods of treating postherpetic neuralgia in a mammal with a pharmaceutical composition comprising a spiro-oxindole compound of the formula: are disclosed. The methods provide excellent penetration of the spiro-oxindole compound into the affected skin area to effectively reduce the severity of the postherpetic neuralgia and/or to alleviate the postherpetic neuralgia with minimal or negligible systemic exposure of the spiro-oxindole compound.
    Type: Application
    Filed: February 5, 2016
    Publication date: August 11, 2016
    Inventors: Michael Fetell, Richard Malamut, Michael J. Lamson, Ofer Spiegelstein, Yigal Paul Goldberg, Nicola Anne Price
  • Formulations and Methods for Attenuating Respiratory Depression Induced by Opioid Overdose
    Publication number: 20160045449
    Abstract: The invention relates to compositions and methods for attenuating opioid induced respiratory depression. Such compositions comprise opioids and sequestered opioid antagonists in a multi-particulate dosage formulation.
    Type: Application
    Filed: October 26, 2015
    Publication date: February 18, 2016
    Inventors: Michael J. Lamson, Veeraindar Goli
  • METHODS OF TREATING PAIN ASSOCIATED WITH OSTEOARTHRITIS OF A JOINT WITH A TOPICAL FORMULATION OF A SPIRO-OXINDOLE COMPOUND
    Publication number: 20150216794
    Abstract: Methods of treating pain associated with osteoarthritis of a joint in a mammal with a pharmaceutical composition comprising a spiro-oxindole compound of the formula: are disclosed. The methods provide excellent penetration of the spiro-oxindole compound into the synovial membrane of the affected joint to effectively reduce the severity of the pain and/or to alleviate the pain with minimal or negligible systemic exposure.
    Type: Application
    Filed: February 5, 2015
    Publication date: August 6, 2015
    Inventors: Michael Fetell, Richard Malamut, Michael J. Lamson, Ofer Spiegelstein, Charles Jay Cohen, Yigal Paul Goldberg, Rostam Namdari, Nicola Anne Price, Katie Jane Webster Proctor
  • Formulations and Methods for Attenuating Respiratory Depression Induced by Opioid Overdose
    Publication number: 20140030343
    Abstract: The invention relates to compositions and methods for attenuating opioid induced respiratory depression. Such compositions comprise opioids and sequestered opioid antagonists in a multi-particulate dosage formulation.
    Type: Application
    Filed: October 25, 2011
    Publication date: January 30, 2014
    Applicant: Alpharma Pharmaceuticals LLC
    Inventors: Michael J. Lamson, Veeraindar Goli